Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TSHA Taysha Gene Therapies, Inc.

元旦休市 12-31 16:00:00 EST

5.50

-0.16

-2.83%

盘后5.53

+0.03+0.55%

19:18 EST

最高5.68	最低5.47	成交量268.75万
今开5.66	昨收5.66	日振幅3.71%
总市值15.07亿	流通市值10.12亿	总股本2.74亿
成交额1,486万	换手率1.46%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":5.5,"timestamp":1767214800000,"preClose":5.66,"halted":0,"volume":2687456,"hourTrading":{"tag":"盘后","latestPrice":5.53,"preClose":5.5,"latestTime":"19:18 EST","volume":51142,"amount":281295.24,"timestamp":1767226695145},"delay":0,"floatShares":184000000,"shares":273919373,"eps":-0.335921,"marketStatus":"元旦休市","change":-0.16,"latestTime":"12-31 16:00:00 EST","open":5.66,"high":5.68,"low":5.47,"amount":14862764.9801952,"amplitude":0.037102,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.335921,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767344400000},"marketStatusCode":7,"adr":0,"listingDate":1600920000000,"exchange":"NASDAQ","adjPreClose":5.66,"preHourTrading":{"tag":"盘前","latestPrice":5.61,"preClose":5.66,"latestTime":"09:15 EST","volume":5676,"amount":31841.820780000002,"timestamp":1767190548066},"postHourTrading":{"tag":"盘后","latestPrice":5.53,"preClose":5.5,"latestTime":"19:18 EST","volume":51142,"amount":281295.24,"timestamp":1767226695145},"volumeRatio":1.848902407023326,"impliedVol":0.2173,"impliedVolPercentile":0.024},"requestUrl":"/m/hq/s/TSHA","defaultTab":"news","newsList":[{"id":"2593734104","title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2593734104","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593734104?lang=zh_cn&edition=full","pubTime":"2025-12-25 06:00","pubTimestamp":1766613621,"startTime":"0","endTime":"0","summary":"杰富瑞近日发布了关于2026年美股生物科技行业的展望报告，聚焦行业首选投资标的、被低估的潜力企业和潜在并购机会。","market":"sg","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385521.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["TSHA","TNGX","TYRA","ORIC","LENZ","SLDB"],"gpt_icon":0},{"id":"2583562799","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.02%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583562799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583562799?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:34","pubTimestamp":1762961640,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时34分，Taysha Gene Therapies, Inc.股票出现波动，股价急速上涨5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223340095003041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223340095003041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2579151013","title":"Taysha Gene Therapies, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579151013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579151013?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:00","pubTimestamp":1761760810,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日02时00分，Taysha Gene Therapies, Inc.股票出现异动，股价快速上涨5.01%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Wave Life Sciences Ltd.涨幅较大，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为4096.17%、2547.31%、419.04%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Purple Biotech Ltd、Ernexa Therapeutics Inc.，振幅分别为139.33%、93.83%、91.19%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103002001094e41968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103002001094e41968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"1180796576","title":"Taysha Gene Therapies Inc：Raymond James 给予强烈买入评级，目标价 $13","url":"https://stock-news.laohu8.com/highlight/detail?id=1180796576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180796576?lang=zh_cn&edition=full","pubTime":"2025-10-21 19:36","pubTimestamp":1761046571,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies Inc：Raymond James 给予强烈买入评级，目标价 $13","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"1100118926","title":"Taysha Gene Therapies重新获得全权领导Tsha-102项目，用于雷特综合症的临床评估","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118926","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100118926?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:02","pubTimestamp":1760644931,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies重新获得全权领导Tsha-102项目，用于雷特综合症的临床评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2572263491","title":"Taysha Gene Therapies, Inc.盘中异动 快速上涨5.33%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572263491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572263491?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:31","pubTimestamp":1759498294,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时31分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅拉升5.33%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Ovid Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Ovid Therapeutics Inc.、Palisade Bio, Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为42.42%、25.79%、13.61%，振幅较大的相关个股有Palisade Bio, Inc.、Shattuck Labs, Inc.、Enveric Biosciences, Inc.，振幅分别为14.71%、7.96%、7.72%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213135971e772a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213135971e772a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2560920824","title":"Taysha Gene Therapies, Inc.2025财年第二财季实现净利润-26.88百万美元，同比减少28.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560920824","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560920824?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:02","pubTimestamp":1755446524,"startTime":"0","endTime":"0","summary":"8月18日，Taysha Gene Therapies, Inc.公布财报，公告显示公司2025财年第二财季净利润为-26.88百万美元，同比减少28.43%；其中营业收入为1.99百万美元，同比增加79.28%，每股基本收益为-0.09美元。从资产负债表来看，Taysha Gene Therapies, Inc.总负债84.60百万美元，其中短期债务2.15百万美元，资产负债比为0.04，流动比率为0.13。机构评级：截至2025年8月18日，当前有12家机构对Taysha Gene Therapies, Inc.目标价做出预测，其中目标均价为8.67美元，其中最低目标价为5.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000439a48deca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000439a48deca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA"],"gpt_icon":0},{"id":"1198284348","title":"异动解读 | 泰沙基因治疗公司发布季度财报后股价盘中大涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198284348","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198284348?lang=zh_cn&edition=full","pubTime":"2025-08-12 22:04","pubTimestamp":1755007458,"startTime":"0","endTime":"0","summary":"泰沙基因治疗公司今日盘中大涨7.25%，引起投资者广泛关注。该公司刚刚公布了截至6月30日的季度财报，虽然每股收益略低于预期，但收入增长强劲，超出市场预期。根据公司发布的财报，泰沙基因治疗公司第二季度调整后每股亏损9美分，与去年同期持平，略低于分析师平均预期的8美分亏损。尽管季度业绩喜忧参半，但华尔街分析师对泰沙基因治疗公司保持乐观态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TSHA"],"gpt_icon":0},{"id":"2555028899","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028899?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:16","pubTimestamp":1753885000,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时16分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅拉升5.34%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302216409727f295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302216409727f295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2551933001","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551933001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551933001?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:28","pubTimestamp":1752589693,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时28分，Taysha Gene Therapies, Inc.股票出现波动，股价急速跳水5.11%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Polyrizon Ltd.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Polyrizon Ltd.、Kairos Pharma, Ltd.较为活跃，换手率分别为1493.04%、1352.92%、1024.90%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为109.47%、75.50%、66.39%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152228139543968c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152228139543968c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2550952740","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952740?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:59","pubTimestamp":1752245956,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时59分，Taysha Gene Therapies, Inc.股票出现波动，股价急速拉升5.10%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Mink Therapeutics, Inc.、Cel-Sci Corporation、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为500.58%、214.91%、82.76%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、74.61%、35.73%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2550229725","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550229725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550229725?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:18","pubTimestamp":1751995125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时18分，Taysha Gene Therapies, Inc.股票出现波动，股价急速上涨5.13%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2548886941","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886941?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:13","pubTimestamp":1751386412,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时13分，Taysha Gene Therapies, Inc.股票出现异动，股价急速上涨5.19%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。Taysha Gene Therapies, Inc.公司简介：泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司，致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2517616939","title":"Taysha Gene Therapies, Inc.盘中异动 大幅上涨5.88%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517616939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517616939?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271471,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Taysha Gene Therapies, Inc.股票出现波动，股价快速上涨5.88%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为920.19%、96.25%、45.65%，振幅较大的相关个股有Astria Therapeutics, Inc.、Mbx Biosciences, Inc.、Plus Therapeutics, Inc.，振幅分别为10.59%、8.18%、8.11%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223111989eb3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223111989eb3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2517469979","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速拉升5.21%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517469979?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:38","pubTimestamp":1741189099,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时38分，Taysha Gene Therapies, Inc.股票出现波动，股价快速上涨5.21%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为867.88%、286.98%、264.83%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为54.27%、42.66%、41.26%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233820989d56ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233820989d56ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2516074548","title":"Taysha Gene Therapies, Inc.2024财年实现净利润-89.30百万美元，同比增加20.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516074548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516074548?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931248,"startTime":"0","endTime":"0","summary":"3月3日，Taysha Gene Therapies, Inc.公布财报，公告显示公司2024财年净利润为-89.30百万美元，同比增加20.27%；其中营业收入为8.33百万美元，同比减少46.08%，每股基本收益为-0.36美元。机构评级：截至2025年3月3日，当前有11家机构对Taysha Gene Therapies, Inc.目标价做出预测，其中目标均价为6.59美元，其中最低目标价为5.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000116abe4acb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000116abe4acb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA"],"gpt_icon":0},{"id":"2514385169","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385169?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:42","pubTimestamp":1740667327,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时42分，Taysha Gene Therapies, Inc.股票出现异动，股价快速上涨6.17%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为453.66%、94.10%、78.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Channel Therapeutics Corporation，振幅分别为41.12%、21.99%、16.89%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272242079632b347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272242079632b347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2514891248","title":"Chardan Capital：维持Taysha Gene Therapies(TSHA.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514891248","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514891248?lang=zh_cn&edition=full","pubTime":"2025-02-27 06:53","pubTimestamp":1740610401,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Taysha Gene Therapies(TSHA.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至7.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27065348414433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TSHA"],"gpt_icon":0},{"id":"1135489441","title":"泰莎基因治疗公司第四季度每股收益$(0.07) 优于预期$(0.08)，销售额$202万低于预期$231万","url":"https://stock-news.laohu8.com/highlight/detail?id=1135489441","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135489441?lang=zh_cn&edition=full","pubTime":"2025-02-26 21:07","pubTimestamp":1740575243,"startTime":"0","endTime":"0","summary":"泰莎基因治疗公司公布其季度每股亏损$，优于分析师一致预期的$，超出预期12.5%。与去年同期每股收益$0.92相比，本次为107.61%的下降。公司报告季度销售额为$202万，低于分析师预期的$231万，差距为12.43%。以上内容来自Benzinga Earnings专栏，原文如下：Taysha Gene Therapies  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is a 107.61 percent decrease over earnings of $0.92 per share from the same period last year.  The company reported quarterly sales of $2.02 million which missed the analyst consensus estimate of $2.31 million by 12.43 perce","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰莎基因治疗公司第四季度每股收益$(0.07) 优于预期$(0.08)，销售额$202万低于预期$231万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2514895011","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514895011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514895011?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:07","pubTimestamp":1740499678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时07分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅拉升5.15%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1243.17%、1101.03%、842.47%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000758a2539d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000758a2539d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":-0.0694},{"period":"1month","weight":0.2415},{"period":"3month","weight":0.127},{"period":"6month","weight":1.2449},{"period":"1year","weight":2.1792},{"period":"ytd","weight":2.1792}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.019},{"period":"6month","weight":0.0905},{"period":"1year","weight":0.1635},{"period":"ytd","weight":0.1635}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司，致力于开发和开发商业化基于AAV的基因疗法，用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177294},{"month":2,"riseRate":0.4,"avgChangeRate":0.109391},{"month":3,"riseRate":0.2,"avgChangeRate":-0.123298},{"month":4,"riseRate":0.4,"avgChangeRate":0.009364},{"month":5,"riseRate":0.4,"avgChangeRate":0.055742},{"month":6,"riseRate":0.2,"avgChangeRate":-0.029545},{"month":7,"riseRate":0.6,"avgChangeRate":0.019307},{"month":8,"riseRate":0.8,"avgChangeRate":0.75256},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089587},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.04036},{"month":11,"riseRate":0.5,"avgChangeRate":0.137875},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.034429}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}